September marks Awareness Month, and this year, the INOVA Schar Adult Center hosted a pivotal town meeting to unite advocates ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

BioCentriq has appointed Syed T. Husain as its new chief executive officer (CEO), and as a member of the Board of Directors.

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

By Andie Bernhardt Click here for updates on this story MILWAUKEE (WDJT) — September is Sickle Cell Awareness Month. Sickle cell is a painful blood disease that’s inherited and affects thousands of ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

GC Therapeutics, Inc. (GCTx), announced its launch today to scale and unlock the next generation of cell therapy. Invented and developed by a world-class team of scientists in the lab of professor ...

Of course, GC Therapeutics could also mean gene and cell therapeutics ... “These are the disease areas that really we believe ...

Penn gene therapy pioneer Dr. Jim Wilson said his decision to leave academia to become full-time CEO of two startups he ...

Age-related musculoskeletal diseases are a significant public health concern that critically impacts the motor functions and the quality of life in the elderly. The musculoskeletal system supports the ...

Stay informed with critical information, news and insights throughout the Boulder Valley and Northern Colorado. AGC Biologics ...

Policy Announcements - On September 6, 2024, the People’s Republic of China’s (PRC) National Development and Reform ...